Daniel Vasella - Novartis
Total Compensation: $17.8 million
Details: In his last year as Novartis' chairman and chief executive, Vasella received a base salary of $2.6 million in 2009, plus short-term incentives of about $99,000, long-term incentives totaling $1.6 million and benefits of about $385,000. He owned 2,924,114 shares in the company. After 14 years as Novartis' CEO, Vasella announced he was stepping down in January. He was replaced by Novartis pharma chief Joe Jimenez (photo).
Vasella, Jimenez share the limelight
Novartis chief steps aside for Jimenez
New Novartis chief talks productivity
Novartis CEO goes on a 'decluttering' drive
Falling Novartis stock deflates bid for Alcon shares